透過您的圖書館登入
IP:3.143.22.26
  • 期刊
  • OpenAccess

Selective Mycobacterium tuberculosis Shikimate Kinase Inhibitors as Potential Antibacterials

並列摘要


Owing to the persistence of tuberculosis (TB) as well as the emergence of multidrug-resistant and extensively drug-resistant (XDR) forms of the disease, the development of new antitubercular drugs is crucial. Developing inhibitors of shikimate kinase (SK) in the shikimate pathway will provide a selective target for antitubercular agents. Many studies have used in silico technology to identify compounds that are anticipated to interact with and inhibit SK. To a much more limited extent, SK inhibition has been evaluated by in vitro methods with purified enzyme. Currently, there are no data on in vivo activity of Mycobacterium tuberculosis shikimate kinase (MtSK) inhibitors available in the literature. In this review, we present a summary of the progress of SK inhibitor discovery and evaluation with particular attention toward development of new antitubercular agents.

被引用紀錄


陳彥甫(2010)。蛋白質-配體結合模式預測與其結合區域定性研究〔博士論文,國立交通大學〕。華藝線上圖書館。https://doi.org/10.6842/NCTU.2010.01062

延伸閱讀